Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy.
Nanotechnological innovations over the last 16 years have brought about the potential to revolutionize specific therapeutic drug delivery to cancer tissue without affecting normal tissues. In addition, there are new nanotechnology-based platforms for diagnosis of cancers and for theranostics, i.e., integrating diagnosis with therapy and follow-up of effectiveness of therapy. This chapter presents an overview of these nanotechnology-based advancements in the areas of prevention, diagnosis, therapy, and theranostics for cancer. In addition, we stress the need to educate bio- and medical students in the field of nanotechnology.
School of Applied Sciences, Mount Ida College, 777 Dedham Street, Newton, MA, 02459, USA. rzeineldin@mountida.edu.
Reema
R
Zeineldin
CVS Health, West Bloomfield, MI, 48301, USA.
Joan
J
Syoufjy
D004337:Drug Carriers; D016503:Drug Delivery Systems; D006801:Humans; D050997:Nanomedicine; D049329:Nanostructures; D036103:Nanotechnology; D009369:Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D012106:Research
D004337:Drug Carriers
Cancer; Drug delivery; Education; Nanocarriers; Targeting; Theranostics